Cargando…

Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment

Detalles Bibliográficos
Autores principales: Costanza, Marco B., Reynolds, Kelly A., Mervak, Julie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433323/
https://www.ncbi.nlm.nih.gov/pubmed/37600732
http://dx.doi.org/10.1016/j.jdcr.2023.06.006
_version_ 1785091624039088128
author Costanza, Marco B.
Reynolds, Kelly A.
Mervak, Julie E.
author_facet Costanza, Marco B.
Reynolds, Kelly A.
Mervak, Julie E.
author_sort Costanza, Marco B.
collection PubMed
description
format Online
Article
Text
id pubmed-10433323
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104333232023-08-18 Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment Costanza, Marco B. Reynolds, Kelly A. Mervak, Julie E. JAAD Case Rep Case Report Elsevier 2023-06-15 /pmc/articles/PMC10433323/ /pubmed/37600732 http://dx.doi.org/10.1016/j.jdcr.2023.06.006 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Costanza, Marco B.
Reynolds, Kelly A.
Mervak, Julie E.
Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
title Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
title_full Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
title_fullStr Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
title_full_unstemmed Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
title_short Management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
title_sort management of treatment-resistant angiolupoid sarcoidosis with adalimumab and tofacitinib 2% ointment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433323/
https://www.ncbi.nlm.nih.gov/pubmed/37600732
http://dx.doi.org/10.1016/j.jdcr.2023.06.006
work_keys_str_mv AT costanzamarcob managementoftreatmentresistantangiolupoidsarcoidosiswithadalimumabandtofacitinib2ointment
AT reynoldskellya managementoftreatmentresistantangiolupoidsarcoidosiswithadalimumabandtofacitinib2ointment
AT mervakjuliee managementoftreatmentresistantangiolupoidsarcoidosiswithadalimumabandtofacitinib2ointment